Abiopharma

Indivior Notification

New Form 144 - INDIVIOR PLC Filed: 2025-08-28 AccNo: 0001974494-25-000091 Size: 4 KB

QIAGEN N.V. Announces Successful Placement of New Net Share Settled Convertible Bonds

New Form 144 - Progyny, Inc. Filed: 2025-08-28 AccNo: 0001959173-25-005596 Size: 4 KB

New Form 6-K - ASTRAZENECA PLC Filed: 2025-08-28 AccNo: 0001654954-25-010131 Size: 17 KB

The latest from NRC Health | Read the August nSight, find the keys to human-centered design, and so much more!

Zealand Pharma to participate in upcoming investor conferences in September 2025

Hemostemix Announces Financing Plans for VesCell™ Treatment

New Form 6-K - Biophytis SA Filed: 2025-08-28 AccNo: 0001104659-25-084446 Size: 27 KB

New Form 8-K - Fulcrum Therapeutics, Inc. Filed: 2025-08-28 AccNo: 0001193125-25-190746 Size: 15 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

PMGC Holdings Inc. Announces Anticipated Reverse Stock Split

New Form 144 - PTC THERAPEUTICS, INC. Filed: 2025-08-28 AccNo: 0001959173-25-005591 Size: 4 KB

SciSparc: AutoMax’s Shareholders Approve Merger with SciSparc

TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance

New Form 6-K - CytoMed Therapeutics Ltd Filed: 2025-08-28 AccNo: 0001641172-25-025761 Size: 39 KB